{"pmid":32378747,"title":"Symmetric cutaneous vasculitis in COVID-19 pneumonia.","text":["Symmetric cutaneous vasculitis in COVID-19 pneumonia.","Fever, cough, breathing difficulties, digestive issues and loss of smell and taste are the most common symptoms of novel SARS-CoV2 infection but cutaneous manifestations have been highlighted by several dermatologists. We found reports (1-3) to be very interesting because it was underlined how the COVID19 infection can also give cutaneous manifestations vasculitis - like. It has already been described how purple in children, when accompanied by fever, can be a rare but possible manifestation of novel SARs-CoV2 infection(4).","J Eur Acad Dermatol Venereol","Castelnovo, Laura","Capelli, Francesca","Tamburello, Antonio","Maria Faggioli, Paola","Mazzone, Antonino","32378747"],"abstract":["Fever, cough, breathing difficulties, digestive issues and loss of smell and taste are the most common symptoms of novel SARS-CoV2 infection but cutaneous manifestations have been highlighted by several dermatologists. We found reports (1-3) to be very interesting because it was underlined how the COVID19 infection can also give cutaneous manifestations vasculitis - like. It has already been described how purple in children, when accompanied by fever, can be a rare but possible manifestation of novel SARs-CoV2 infection(4)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Castelnovo, Laura","Capelli, Francesca","Tamburello, Antonio","Maria Faggioli, Paola","Mazzone, Antonino"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32378747","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jdv.16589","keywords":["covid-19","medical dermatology","pneumonia","vasculitis"],"topics":["Diagnosis"],"weight":1,"_version_":1666262687571509248,"score":9.490897,"similar":[{"pmid":32453865,"title":"Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).","text":["Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global health issue. Although it is known to produce diverse cutaneous manifestations, some of them have yet to be described. This letter reports new dermatologic findings associated with a confirmed COVID-19 case.","J Eur Acad Dermatol Venereol","Dominguez-Santas, M","Diaz-Guimaraens, B","Garcia Abellas, P","Moreno-Garcia Del Real, C","Burgos-Blasco feminine, P","Suarez-Valle, A","32453865"],"abstract":["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global health issue. Although it is known to produce diverse cutaneous manifestations, some of them have yet to be described. This letter reports new dermatologic findings associated with a confirmed COVID-19 case."],"journal":"J Eur Acad Dermatol Venereol","authors":["Dominguez-Santas, M","Diaz-Guimaraens, B","Garcia Abellas, P","Moreno-Garcia Del Real, C","Burgos-Blasco feminine, P","Suarez-Valle, A"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453865","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jdv.16663","keywords":["coronavirus","dermatology","outbreak","travelers health","vasculitis","virus"],"topics":["Case Report"],"weight":1,"_version_":1667983494481969152,"score":212.7484},{"pmid":32381430,"pmcid":"PMC7189855","title":"Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.","text":["Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.","BACKGROUND: Various cutaneous manifestations have been observed in patients with COVID-19 infection. However, overall similarities in the clinical presentation of these dermatological manifestations have not yet been summarized. OBJECTIVE: This review aims to provide an overview of various cutaneous manifestations in patients with COVID-19 through three case reports and a literature review. METHODS: A literature search was conducted using PubMed, OVID, and Google search engines for original and review articles. Studies written in the English language that mentioned cutaneous symptoms and COVID-19 were included. RESULTS: Eighteen articles and three additional cases reported in this paper were included in this review. Of these studies, 6 are case series and 12 are case report studies. The most common cutaneous manifestation of COVID-19 was found to be maculopapular exanthem (morbilliform), presenting in 36.1% (26/72) patients. The other cutaneous manifestations included: a papulovesicular rash (34.7%, 25/72), urticaria (9.7%, 7/72), painful acral red purple papules (15.3%, 11/72) of patients, livedo reticularis lesions (2.8%, 2/72) and petechiae (1.4%, 1/72). Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet. Skin lesion development occurred before the onset of respiratory symptoms or COVID-19 diagnosis in 12.5% (9/72) of the patients, and lesions spontaneously healed in all patients within 10 days. Majority of the studies reported no correlation between COVID-19 severity and skin lesions. CONCLUSION: Infection with COVID-19 may result in dermatological manifestations with various clinical presentations, which may aid in the timely diagnosis of this infection.","J Dermatol Sci","Sachdeva, Muskaan","Gianotti, Raffaele","Shah, Monica","Lucia, Bradanini","Tosi, Diego","Veraldi, Stefano","Ziv, Michael","Leshem, Eyal","Dodiuk-Gad, Roni P","32381430"],"abstract":["BACKGROUND: Various cutaneous manifestations have been observed in patients with COVID-19 infection. However, overall similarities in the clinical presentation of these dermatological manifestations have not yet been summarized. OBJECTIVE: This review aims to provide an overview of various cutaneous manifestations in patients with COVID-19 through three case reports and a literature review. METHODS: A literature search was conducted using PubMed, OVID, and Google search engines for original and review articles. Studies written in the English language that mentioned cutaneous symptoms and COVID-19 were included. RESULTS: Eighteen articles and three additional cases reported in this paper were included in this review. Of these studies, 6 are case series and 12 are case report studies. The most common cutaneous manifestation of COVID-19 was found to be maculopapular exanthem (morbilliform), presenting in 36.1% (26/72) patients. The other cutaneous manifestations included: a papulovesicular rash (34.7%, 25/72), urticaria (9.7%, 7/72), painful acral red purple papules (15.3%, 11/72) of patients, livedo reticularis lesions (2.8%, 2/72) and petechiae (1.4%, 1/72). Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet. Skin lesion development occurred before the onset of respiratory symptoms or COVID-19 diagnosis in 12.5% (9/72) of the patients, and lesions spontaneously healed in all patients within 10 days. Majority of the studies reported no correlation between COVID-19 severity and skin lesions. CONCLUSION: Infection with COVID-19 may result in dermatological manifestations with various clinical presentations, which may aid in the timely diagnosis of this infection."],"journal":"J Dermatol Sci","authors":["Sachdeva, Muskaan","Gianotti, Raffaele","Shah, Monica","Lucia, Bradanini","Tosi, Diego","Veraldi, Stefano","Ziv, Michael","Leshem, Eyal","Dodiuk-Gad, Roni P"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381430","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jdermsci.2020.04.011","keywords":["covid-19","cutaneous manifestations","review","skin"],"topics":["Case Report"],"weight":1,"_version_":1666419683361816576,"score":180.5193},{"pmid":32390279,"title":"Cutaneous Signs in COVID-19 Patients: A Review.","text":["Cutaneous Signs in COVID-19 Patients: A Review.","COVID-19 pandemic caused by beta-coronavirus SARS-CoV-2 primarily affects the epithelium of the airways. With the increasing involvement of dermatologist in management of this crisis, cutaneous symptoms gained more and more attention. In this review we will describe cutaneous symptoms of patients of all ages in association with COVID-19. We will focus on such disorders that are caused by direct action of the SARS-CoV-2 virus on tissues, complement and coagulation system and on non-specific eruption of the systemic viral infection. Drug-induced reactions are only mentioned in the differential diagnoses. Although more systematic investigations are warranted, it comes clear that some symptoms are clinical signs of a milder COVID-19 course, while others are a red flag for a more severe course. Knowledge of the cutaneous manifestations of COVID-19 may help in early diagnosis, triage of patients and risk stratification. This article is protected by copyright. All rights reserved.","Dermatol Ther","Wollina, Uwe","Karadag, Ayse Serap","Rowland-Payne, Christopher","Chiriac, Anca","Lotti, Torello","32390279"],"abstract":["COVID-19 pandemic caused by beta-coronavirus SARS-CoV-2 primarily affects the epithelium of the airways. With the increasing involvement of dermatologist in management of this crisis, cutaneous symptoms gained more and more attention. In this review we will describe cutaneous symptoms of patients of all ages in association with COVID-19. We will focus on such disorders that are caused by direct action of the SARS-CoV-2 virus on tissues, complement and coagulation system and on non-specific eruption of the systemic viral infection. Drug-induced reactions are only mentioned in the differential diagnoses. Although more systematic investigations are warranted, it comes clear that some symptoms are clinical signs of a milder COVID-19 course, while others are a red flag for a more severe course. Knowledge of the cutaneous manifestations of COVID-19 may help in early diagnosis, triage of patients and risk stratification. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Wollina, Uwe","Karadag, Ayse Serap","Rowland-Payne, Christopher","Chiriac, Anca","Lotti, Torello"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32390279","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/dth.13549","keywords":["acro-ischemia","androgenetic alopecia","covid-19","chilblain-like eruptions","maculopapular rash","purpuric rash","sars-cov-2","urticaria"],"topics":["Diagnosis"],"weight":1,"_version_":1666528580020994048,"score":174.72089},{"pmid":32479680,"title":"Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.","text":["Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.","BACKGROUND: The infection caused by the recently identified SARS-CoV-2, called COronaVIrus Disease-19 (COVID-19), has rapidly spread throughout the world. With the exponential increase of patients worldwide, the clinical spectrum of COVID-19 is being better defined and new symptoms are emerging. Numerous reports are documenting the occurrence of different cutaneous manifestations in COVID-19 patients. OBJECTIVES: To provide a brief overview of the COVID-19-associated cutaneous lesions. METHODS: Literature search was performed in the PubMed, Scopus and Web of Science databases up to 30 April 2020. This narrative review summarizes the available data regarding clinical and histological features of COVID-19-associated skin manifestations. RESULTS: Literature reports showed a great heterogeneity in COVID-19-associated cutaneous manifestations, as well as in their latency periods and associated extracutaneous symptoms. Pathogenic mechanisms are unknown, although the role of hyperactive immune response, complement activation and microvascular injury has been hypothesized. Based on our experience and the literature data, we subdivided the reported cutaneous lesions into six main clinical patterns: i) urticarial rash, ii) confluent erythematous/maculo-papular/morbilliform rash, iii) papulovesicular exanthem, iv) chilblain-like acral pattern, v) livedo reticularis/racemosa-like pattern, vi) purpuric \"vasculitic\" pattern. These six patterns can be merged into two main settings: the first one - inflammatory/exanthematous - including the first three groups cited above and the second one including the vasculopathic/vasculitic lesions of the last three aforementioned groups. CONCLUSIONS: The possible presence of cutaneous findings leading to suspect COVID-19 puts dermatologists in a relevant position. Further studies are needed to delineate the diagnostic and prognostic value of such cutaneous manifestations.","Br J Dermatol","Marzano, A V","Cassano, N","Genovese, G","Moltrasio, C","Vena, G A","32479680"],"abstract":["BACKGROUND: The infection caused by the recently identified SARS-CoV-2, called COronaVIrus Disease-19 (COVID-19), has rapidly spread throughout the world. With the exponential increase of patients worldwide, the clinical spectrum of COVID-19 is being better defined and new symptoms are emerging. Numerous reports are documenting the occurrence of different cutaneous manifestations in COVID-19 patients. OBJECTIVES: To provide a brief overview of the COVID-19-associated cutaneous lesions. METHODS: Literature search was performed in the PubMed, Scopus and Web of Science databases up to 30 April 2020. This narrative review summarizes the available data regarding clinical and histological features of COVID-19-associated skin manifestations. RESULTS: Literature reports showed a great heterogeneity in COVID-19-associated cutaneous manifestations, as well as in their latency periods and associated extracutaneous symptoms. Pathogenic mechanisms are unknown, although the role of hyperactive immune response, complement activation and microvascular injury has been hypothesized. Based on our experience and the literature data, we subdivided the reported cutaneous lesions into six main clinical patterns: i) urticarial rash, ii) confluent erythematous/maculo-papular/morbilliform rash, iii) papulovesicular exanthem, iv) chilblain-like acral pattern, v) livedo reticularis/racemosa-like pattern, vi) purpuric \"vasculitic\" pattern. These six patterns can be merged into two main settings: the first one - inflammatory/exanthematous - including the first three groups cited above and the second one including the vasculopathic/vasculitic lesions of the last three aforementioned groups. CONCLUSIONS: The possible presence of cutaneous findings leading to suspect COVID-19 puts dermatologists in a relevant position. Further studies are needed to delineate the diagnostic and prognostic value of such cutaneous manifestations."],"journal":"Br J Dermatol","authors":["Marzano, A V","Cassano, N","Genovese, G","Moltrasio, C","Vena, G A"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479680","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/bjd.19264","topics":["Diagnosis"],"weight":1,"_version_":1668532089570459648,"score":173.21864},{"pmid":32314436,"title":"Comment on \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S.","text":["Comment on \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S.","Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than 1,000,000 persons worldwide, of whom over 50,000 have died (1). Having been infected by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), patients with COVID-19 mainly present with fever and respiratory symptoms (2). Isolated sudden onset anosmia has also frequently been reported (3). Less frequently, rhinorrhea, diarrhoea and dysgeusia may be associated. While only a few reports have evoked cutaneous manifestations (4), we read with interest an initial study on the topic entitled \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S. (5).","J Eur Acad Dermatol Venereol","Hedou, M","Carsuzaa, F","Chary, E","Hainaut, E","Cazenave-Roblot, F","Masson Regnault, M","32314436"],"abstract":["Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than 1,000,000 persons worldwide, of whom over 50,000 have died (1). Having been infected by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), patients with COVID-19 mainly present with fever and respiratory symptoms (2). Isolated sudden onset anosmia has also frequently been reported (3). Less frequently, rhinorrhea, diarrhoea and dysgeusia may be associated. While only a few reports have evoked cutaneous manifestations (4), we read with interest an initial study on the topic entitled \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S. (5)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Hedou, M","Carsuzaa, F","Chary, E","Hainaut, E","Cazenave-Roblot, F","Masson Regnault, M"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314436","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16519","keywords":["covid-19 infections","cutaneous manifestations","skin"],"locations":["Chinese","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493420568576,"score":172.03156}]}